SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-248666
Filing Date
2024-10-31
Accepted
2024-10-31 16:07:43
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B3 d835714d424b3.htm 424B3 2591552
2 GRAPHIC g835714g00n96.jpg GRAPHIC 129950
3 GRAPHIC g835714g01n01.jpg GRAPHIC 152293
4 GRAPHIC g835714g01n03.jpg GRAPHIC 131380
5 GRAPHIC g835714g01n04.jpg GRAPHIC 111171
6 GRAPHIC g835714g04t36.jpg GRAPHIC 59618
7 GRAPHIC g835714g16r22.jpg GRAPHIC 214633
8 GRAPHIC g835714g18c09.jpg GRAPHIC 60428
9 GRAPHIC g835714g28n82.jpg GRAPHIC 64287
10 GRAPHIC g835714g31g31.jpg GRAPHIC 142900
11 GRAPHIC g835714g35j50.jpg GRAPHIC 31695
12 GRAPHIC g835714g63o33.jpg GRAPHIC 146126
13 GRAPHIC g835714g88b55.jpg GRAPHIC 75513
14 GRAPHIC g835714g98j04.jpg GRAPHIC 194487
  Complete submission text file 0001193125-24-248666.txt   4641839
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282792 | Film No.: 241415274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)